Stonepine Capital Management’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.02M | Sell |
190,590
-16,049
| -8% | -$170K | 1.98% | 15 |
|
|
2025
Q1 | $3.26M | Sell |
206,639
-31,583
| -13% | -$498K | 3.17% | 8 |
|
|
2024
Q4 | $3.92M | Buy |
238,222
+48,914
| +26% | +$805K | 3.17% | 9 |
|
|
2024
Q3 | $4.68M | Buy |
189,308
+23,911
| +14% | +$591K | 2.95% | 9 |
|
|
2024
Q2 | $4.19M | Buy |
165,397
+104,448
| +171% | +$2.65M | 3.82% | 7 |
|
|
2024
Q1 | $1.55M | Buy |
+60,949
| New | +$1.55M | 1.23% | 12 |
|